Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 16, 2016
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
Patrizia Viola, Manisha Maurya, James Croud, et al.
Journal of Clinical Pathology
|
May 31, 2023
Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey
Phillipe Taniere, Andrew G Nicholson, John R Gosney, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 13, 2016
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs
Caterina Conti, Angeles Montero-Fernandez, Elaine Borg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 11, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [<sup>18</sup>F]FDG PET/CT radiomics
Mitchell Chen, Susan J Copley, Yidong Han, et al.
JTO Clinical and Research Reports
|
November 8, 2021
Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations
Giuseppe Pelosi, Matteo Bulloni, Martina Vescio, et al.
The Lancet. Microbe
|
August 27, 2020
Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study
Brian Hanley, Kikkeri N Naresh, Candice Roufosse, et al.
JAMA Oncology
|
November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC
Mehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Oncotarget
|
July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
Luca Magnani, Darren K Patten, Van T M Nguyen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 12, 2017
Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung
Andrew G Nicholson, Kathleen Torkko, Patrizia Viola, et al.
Cancer Cytopathology
|
October 27, 2020
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries
Elena Vigliar, Rima Cepurnaite, Eduardo Alcaraz-Mateos, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 16, 2016
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
Patrizia Viola, Manisha Maurya, James Croud, et al.
Journal of Clinical Pathology
|
May 31, 2023
Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey
Phillipe Taniere, Andrew G Nicholson, John R Gosney, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 13, 2016
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs
Caterina Conti, Angeles Montero-Fernandez, Elaine Borg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 11, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [<sup>18</sup>F]FDG PET/CT radiomics
Mitchell Chen, Susan J Copley, Yidong Han, et al.
JTO Clinical and Research Reports
|
November 8, 2021
Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations
Giuseppe Pelosi, Matteo Bulloni, Martina Vescio, et al.
The Lancet. Microbe
|
August 27, 2020
Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study
Brian Hanley, Kikkeri N Naresh, Candice Roufosse, et al.
JAMA Oncology
|
November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC
Mehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Oncotarget
|
July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
Luca Magnani, Darren K Patten, Van T M Nguyen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 12, 2017
Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung
Andrew G Nicholson, Kathleen Torkko, Patrizia Viola, et al.
Cancer Cytopathology
|
October 27, 2020
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries
Elena Vigliar, Rima Cepurnaite, Eduardo Alcaraz-Mateos, et al.
Page
of 4